Weijun Fu
Papers
1
Total Citations
19
H-Index
1
About
Weijun Fu is a pioneering urologic surgeon whose work is reshaping the diagnosis and treatment of prostate cancer. His research centers on the integration of advanced imaging—specifically, PSMA PET/CT and multiparametric MRI—to guide surgical decision-making. Dr. Fu’s most notable contribution is a groundbreaking single-center, prospective trial that tested the feasibility of performing radical prostatectomy *without* prior biopsy in select patients. By using PSMA-ligand PET/CT and MRI to identify high-risk lesions, his team demonstrated that immediate surgery could be a safe, streamlined alternative to the traditional biopsy-first pathway. This paradigm-shifting work, published in 2024, has already garnered 19 citations, reflecting its immediate impact on clinical debate. Dr. Fu’s research challenges long-held standards, aiming to reduce patient anxiety, avoid biopsy complications, and accelerate definitive treatment. His work is a compelling example of how precision imaging is enabling more efficient, patient-centered cancer care, and positions him as a key voice in the future of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1